Over the past two decades, pharmaceutical companies have expanded their focus in new drug development efforts beyond small molecules to include large molecules or biopharmaceuticals. In a September 2016 publication by EvaluatePharma 1, they estimated by 2022, biologic drugs will contribute 50 per cent of the top 100 pharmaceutical product sales. Biopharmaceuticals have been called the most sophisticated and elegant achievements of modern science (Otto et al, 20142).
Lisa Sapp
Get in touch with Lisa
Contact Lisa, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack